Reveals NK cell dysregulation in HIV, suggesting new immunotherapy insights.
BACKGROUND: Natural killer (NK) cells, as an integral component of the innate immune system, assume a pivotal role in combating viral infections. Our understanding of how human immunodeficiency virus (HIV) infection affects NK cell heterogeneity remains limited. METHODS: T cells. FINDINGS: NK-MKI67, increased following HIV infection, enriched in S and G2/M phases cells, respectively, with distinct metabolic profiles. Notably, the cytotoxicity score of the c5-Transitional NK subset before ART was associated with HIV-DNA decline over time. INTERPRETATION: Our findings offer a comprehensive understanding of the cellular and molecular heterogeneity of NK cell immune response during HIV infection and offer insights for NK cell-based immunotherapies. FUNDING: Supported by grants from the National Natural Science Foundation of China (No. 82371766, 82572006, 82101837, and 82271857).
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: